Incyte News

Leerink Partners Maintains Incyte(INCY.US) With Buy Rating, Cuts Target Price to $92

Futu NewsMar 25 13:32

Analysts Offer Insights on Healthcare Companies: InflaRx (IFRX), Eli Lilly & Co (LLY) and Incyte (INCY)

TipRanksMar 25 08:46

Incyte Is Maintained at Equal-Weight by Morgan Stanley

Dow JonesMar 24 19:57

Incyte Analyst Ratings

BenzingaMar 24 19:48

Morgan Stanley Maintains Incyte(INCY.US) With Hold Rating, Cuts Target Price to $65

Futu NewsMar 24 18:31

Incyte's Hold Rating: Balancing Pipeline Challenges and Established Product Valuation

TipRanksMar 24 17:59

William Blair Maintains Incyte(INCY.US) With Hold Rating

Futu NewsMar 23 07:32

Incyte (INCY) Was Downgraded to a Hold Rating at William Blair

TipRanksMar 22 22:59

Monday.com, Incyte, Lucid, Bloom, EQT: Trending by Analysts

TipRanksMar 22 17:03

Incyte Is Maintained at Hold by Truist Securities

Dow JonesMar 18 22:20

Incyte Price Target Maintained With a $92.00/Share by Guggenheim

Dow JonesMar 18 22:14

Truist Securities Maintains Hold on Incyte, Lowers Price Target to $72

BenzingaMar 18 22:10

A Quick Look at Today's Ratings for Incyte(INCY.US), With a Forecast Between $68 to $100

Futu NewsMar 18 21:00

Incyte Analyst Ratings

BenzingaMar 18 19:35

Incyte's Stock Downgraded to Sell Amid Disappointing Drug Data and Market Challenges

TipRanksMar 18 19:31

Incyte (INCY) Receives a Hold From Wells Fargo

TipRanksMar 18 18:27

Incyte's Promising Phase 3 Results and Market Potential Drive Buy Rating

TipRanksMar 18 18:06

Incyte (INCY) Was Downgraded to a Hold Rating at William Blair

TipRanksMar 18 16:28

TD Cowen Reaffirms Their Buy Rating on Incyte (INCY)

TipRanksMar 18 05:52

Wells Fargo Cuts Price Target on Incyte to $58 From $70

MT NewswiresMar 17 22:33